PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23623333-4	2013	The pharmacodynamics for alpha4 integrin antagonism of AJM300 was investigated in mice.	AJM300	55-61	immunoglobulin (CD79A) binding protein 1	Mus musculus	25-31	
23623333-11	2013	CONCLUSIONS: Oral treatment with the selective small molecule alpha4 integrin antagonist (AJM300) prevented the development of colitis and its efficacy was comparable to that of the anti-alpha4 integrin antibody.	AJM300	90-96	immunoglobulin (CD79A) binding protein 1	Mus musculus	62-68